AtriCure Provides Earnings Guidance for the Fourth Quarter of 2016, Full Year 2017 and 2018; Revises EBITDA Guidance for the Full Year of 2016
January 09, 2017 at 08:00 am
Share
AtriCure provided earnings guidance for the fourth quarter of 2016, full year 2017 and 2018. The company expects preliminary and unaudited revenue for fourth quarter 2016 is expected to be approximately $41.2 million, reflecting growth of approximately 15% over the fourth quarter of 2015.
The company expects preliminary revenue for full year 2016 is expected to be $155.1 million, reflecting growth of approximately 20% over full year 2015. The Adjusted EBITDA loss (a non-GAAP measure consistently calculated as in previous releases) for the full year 2016 is currently estimated to be less than the previously communicated range of $12 to $14 million.
The company expects management projects 2017 revenue growth of approximately 13% to 15% over full year 2016 at current exchange rates. Adjusted EBITDA, a non-GAAP measure, is projected to be a loss in the range of $4 to $6 million for 2017. Net loss per share is expected to be in the range of $0.88 to $0.96. The company continues to expect positive adjusted EBITDA for full year 2018.
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
ATRICURE, INC. 
